Plain-English translation of NCT06294028 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial compares two treatment options for people who have experienced dangerous irregular heartbeats due to prior heart attacks. You would receive either ablation therapy (a procedure that uses heat to fix the problematic heart tissue) or an implantable defibrillator device (a small device placed under your skin that can detect and correct dangerous rhythms). Researchers want to learn which approach works better for people whose heart's pumping function is only mildly reduced.
Doctors aren't sure which treatment is best for your specific situation โ people whose hearts are still pumping reasonably well but have had dangerous irregular heartbeats. Recent evidence suggests that ablation therapy may reduce repeat episodes and even death risk, but it's never been directly compared to a defibrillator device in this patient group.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to receive either ablation therapy or a defibrillator implant. With ablation, you'll have a procedure where doctors use heat through a catheter to treat the problematic heart tissue. With the defibrillator, a small device is surgically placed under your skin to monitor and correct dangerous rhythms if they occur. You'll have follow-up visits to monitor your progress and check for any recurring irregular heartbeats over time.
AI-generated summary from trial data ยท Jun 11, 2026 ยท Not medical advice
France